A Case-control Study of Polymorphisms in Xenobiotic and Arsenic Metabolism Genes and Arsenic-related Bladder Cancer in New Hampshire

Overview

Journal Toxicol Lett

Publisher Elsevier

Specialty Toxicology

Date 2012 Feb 7

PMID 22306368

Citations 30

Authors

Corina Lesseur

Diane Gilbert-Diamond

Angeline S Andrew

Rebecca M Ekstrom

Zhongze Li

Karl T Kelsey

Carmen J Marsit

Margaret R Karagas

Affiliations

Soon will be listed here.

Abstract

Arsenic is associated with bladder cancer risk even at low exposure levels. Genetic variation in enzymes involved in xenobiotic and arsenic metabolism may modulate individual susceptibility to arsenic-related bladder cancer. Through a population-based case-control study in NH (832 cases and 1191 controls), we investigated gene-environment interactions between arsenic metabolic gene polymorphisms and arsenic exposure in relation to bladder cancer risk. Toenail arsenic concentrations were used to classify subjects into low and high exposure groups. Single nucleotide polymorphisms (SNPs) in GSTP1, GSTO2, GSTZ1, AQP3, AS3MT and the deletion status of GSTM1 and GSTT1 were determined. We found evidence of genotype-arsenic interactions in the high exposure group; GSTP1 Ile105Val homozygous individuals had an odds ratio (OR) of 5.4 [95% confidence interval (CI): 1.5-20.2; P for interaction=0.03] and AQP3 Phe130Phe carriers had an OR=2.2 (95% CI: 0.8-6.1; P for interaction=0.10). Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06). Our findings suggest that susceptibility to bladder cancer may relate to variation in genes involved in arsenic metabolism and oxidative stress response and potential gene-environment interactions requiring confirmation in other populations.

Citing Articles

Decoding Cancer Risk: Understanding Gene-Environment Interactions in Cancer Development.

Sandhu A, Tanvir , Singh K, Singh S, Antaal H, Luthra S Cureus. 2024; 16(7):e64936.

PMID: 39165474 PMC: 11335134. DOI: 10.7759/cureus.64936.

Association between urinary arsenic concentration and genetic polymorphisms in Korean adults.

Lee S, Eom S, Lim J, Choi B, Kwon H, Hong Y Toxicol Res. 2024; 40(1):179-188.

PMID: 38223675 PMC: 10786758. DOI: 10.1007/s43188-023-00216-x.

The Polymorphisms in Genes ( rs4925, rs156697, and rs2297235) Affect the Risk for Testicular Germ Cell Tumor Development: A Pilot Study.

Petrovic M, Simic T, Djukic T, Radic T, Savic-Radojevic A, Zekovic M Life (Basel). 2023; 13(6).

PMID: 37374052 PMC: 10301167. DOI: 10.3390/life13061269.

Impact of Gene-Environment Interactions on Cancer Development.

Mbemi A, Khanna S, Njiki S, Yedjou C, Tchounwou P Int J Environ Res Public Health. 2020; 17(21).

PMID: 33153024 PMC: 7662361. DOI: 10.3390/ijerph17218089.

Toenails as a biomarker of exposure to arsenic: A review.

Signes-Pastor A, Gutierrez-Gonzalez E, Garcia-Villarino M, Rodriguez-Cabrera F, Lopez-Moreno J, Varea-Jimenez E Environ Res. 2020; 195:110286.

PMID: 33075355 PMC: 7987585. DOI: 10.1016/j.envres.2020.110286.

References

Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36. DOI: 10.3322/caac.20121. View

Hsu L, Chen W, Yang T, Chen Y, Lo W, Wang Y . Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. J Biomed Sci. 2011; 18:51. PMC: 3199751. DOI: 10.1186/1423-0127-18-51. View

Bates M, Smith A, Cantor K . Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol. 1995; 141(6):523-30. DOI: 10.1093/oxfordjournals.aje.a117467. View

Steinmaus C, Yuan Y, Bates M, Smith A . Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol. 2003; 158(12):1193-201. DOI: 10.1093/aje/kwg281. View

Drobna Z, Waters S, Walton F, LeCluyse E, Thomas D, Styblo M . Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol Appl Pharmacol. 2004; 201(2):166-77. DOI: 10.1016/j.taap.2004.05.004. View

Cheng T, Christiani D, Wiencke J, Wain J, Xu X, Kelsey K . Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat Res. 1995; 348(2):75-82. DOI: 10.1016/0165-7992(95)00049-6. View

Zhang R, Xu G, Chen W, Zhang W . Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies. Mol Biol Rep. 2010; 38(4):2491-7. DOI: 10.1007/s11033-010-0386-6. View

Karagas M, Andrew A, Nelson H, Li Z, Punshon T, Schned A . SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Hum Genet. 2011; 131(3):453-61. PMC: 3278547. DOI: 10.1007/s00439-011-1090-x. View

Zhong S, Zhou S, Chen X, Chan S, Chan E, Ng K . Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur J Pharm Sci. 2006; 28(1-2):77-85. DOI: 10.1016/j.ejps.2006.01.002. View

10.

Wang Y, Yeh S, Shen K, Shen C, Juang G, Hsu L . A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. Toxicol Appl Pharmacol. 2009; 241(1):111-8. DOI: 10.1016/j.taap.2009.08.008. View

11.

Zakharyan R, Sampayo-Reyes A, Healy S, Tsaprailis G, Board P, Liebler D . Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol. 2001; 14(8):1051-7. DOI: 10.1021/tx010052h. View

12.

Karagas M, Tosteson T, Blum J, Morris J, Baron J, Klaue B . Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect. 1998; 106 Suppl 4:1047-50. PMC: 1533320. DOI: 10.1289/ehp.98106s41047. View

13.

. Some drinking-water disinfectants and contaminants, including arsenic. Monographs on chloramine, chloral and chloral hydrate, dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone. IARC Monogr Eval Carcinog Risks Hum. 2005; 84:269-477. PMC: 5220262. View

14.

Lin S, Shi Q, Nix F, Styblo M, Beck M, Herbin-Davis K . A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem. 2002; 277(13):10795-803. DOI: 10.1074/jbc.M110246200. View

15.

Agusa T, Kunito T, Tue N, Thi Mai Lan V, Fujihara J, Takeshita H . Individual variations in arsenic metabolism in Vietnamese: the association with arsenic exposure and GSTP1 genetic polymorphism. Metallomics. 2011; 4(1):91-100. DOI: 10.1039/c1mt00133g. View

16.

Karagas M, Park S, Warren A, Hamilton J, Nelson H, Mott L . Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett. 2005; 219(1):63-9. DOI: 10.1016/j.canlet.2004.10.006. View

17.

Valenzuela O, Drobna Z, Hernandez-Castellanos E, Sanchez-Pena L, Garcia-Vargas G, Borja-Aburto V . Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol Appl Pharmacol. 2009; 239(2):200-7. PMC: 2910909. DOI: 10.1016/j.taap.2009.06.007. View

18.

Karagas M, Tosteson T, Blum J, Klaue B, Weiss J, Stannard V . Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol. 2000; 152(1):84-90. DOI: 10.1093/aje/152.1.84. View

19.

Chung C, Pu Y, Su C, Huang C, Hsueh Y . Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma. Sci Total Environ. 2010; 409(3):465-70. DOI: 10.1016/j.scitotenv.2010.10.053. View

20.

Yamanaka K, Hasegawa A, Sawamura R, Okada S . Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem Biophys Res Commun. 1989; 165(1):43-50. DOI: 10.1016/0006-291x(89)91031-0. View